↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$1.3MSold on the market
1Companies
Sep 11, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 202616:05 | Sep 10, 2026 | TVTXTravere Therapeutics, Inc. | Director | S · Sell10b5-1 | $67.31 | −20,000 | 91,500 | -18% | −$1.3M | ||
| Sep 11, 202616:05 | Sep 10, 2026 | TVTXTravere Therapeutics, Inc. | Director | M · Exercise10b5-1 | $21.98 | +20,000 | 111,500 | +22% | $440K |